ARIEL3: A phase 3, randomized, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian cancer (OC) Meeting Abstract
| Authors: | Coleman, R. L.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A.; Scambia, G.; Leary, A.; Holloway, R. W.; O'Malley, D. M.; Cameron, T.; Maloney, L.; Goble, S.; Lin, K.; Sun, J.; Giordano, H.; Ledermann, J. A. |
| Abstract Title: | ARIEL3: A phase 3, randomized, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian cancer (OC) |
| Meeting Title: | AACR Special Conference: Addressing Critical Questions in Ovarian Cancer Research and Treatment |
| Journal Title: | Clinical Cancer Research |
| Volume: | 24 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Oct 1-4 |
| Meeting Location: | Pittsburgh, PA |
| ISSN: | 1078-0432 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2018-08-01 |
| Start Page: | 30 |
| End Page: | 31 |
| Language: | English |
| ACCESSION: | WOS:000440823600029 |
| PROVIDER: | wos |
| DOI: | 10.1158/1557-3265.OVCA17-PR06 |
| Notes: | Meeting Abstract: PR06 -- Source: Wos |
